These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1906711)

  • 21. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
    Hill-Eubanks DC; Lollar P
    J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High level expression of recombinant porcine coagulation factor VIII.
    Doering CB; Healey JF; Parker ET; Barrow RT; Lollar P
    J Biol Chem; 2002 Oct; 277(41):38345-9. PubMed ID: 12138172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
    Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of factor VIII 1,689-Cys: a nonfunctional cofactor occurring in a patient with severe hemophilia A.
    O'Brien DP; Tuddenham EG
    Blood; 1989 Jun; 73(8):2117-22. PubMed ID: 2499363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The size of human factor VIII heterodimers and the effects produced by thrombin.
    Fay PJ; Anderson MT; Chavin SI; Marder VJ
    Biochim Biophys Acta; 1986 Jun; 871(3):268-78. PubMed ID: 3085715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of different activated forms of factor VIII, the human antihemophilic A factor.
    Bihoreau N; Sauger A; Yon JM; Van de Pol H
    Eur J Biochem; 1989 Oct; 185(1):111-8. PubMed ID: 2509202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.
    Kaufman RJ; Wasley LC; Dorner AJ
    J Biol Chem; 1988 May; 263(13):6352-62. PubMed ID: 3129422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of biologically active human factor VIII using a baculovirus vector.
    Webb E; Tkalcevic J; Edwards S; Hocking D; Nisbet I
    Biochem Biophys Res Commun; 1993 Jan; 190(2):536-43. PubMed ID: 8427596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation, activity and inactivation of factor VIII in factor VIII products.
    Orfeo T; Elsman R; Gissel M; Mann KG; Butenas S
    Haemophilia; 2016 May; 22(3):462-73. PubMed ID: 26822998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.
    Lollar P; Parker ET
    J Biol Chem; 1991 Jul; 266(19):12481-6. PubMed ID: 1905722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
    Geng JP; Castellino FJ
    Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.
    Oh HK; Lee JM; Byun TH; Park SY; Kim YH
    Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII and factor VIIIa.
    Lollar P; Fay PJ; Fass DN
    Methods Enzymol; 1993; 222():128-43. PubMed ID: 8412790
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
    Hill-Eubanks DC; Parker CG; Lollar P
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human factor VIII and interaction with von Willebrand factor. An electron microscopic study.
    Heijnen HF; Koedam JA; Sandberg H; Beeser-Visser NH; Slot JW; Sixma JJ
    Eur J Biochem; 1990 Dec; 194(2):491-8. PubMed ID: 2125268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
    Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
    Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIII.
    Mikkelsen J; Thomsen J; Ezban M
    Biochemistry; 1991 Feb; 30(6):1533-7. PubMed ID: 1899619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.
    Andersson LO; Forsman N; Huang K; Larsen K; Lundin A; Pavlu B; Sandberg H; Sewerin K; Smart J
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2979-83. PubMed ID: 3085106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.